Abstract PD4-07: Subcutaneous administration of the fixed-dose combination of trastuzumab and pertuzumab in combination with chemotherapy in HER2-positive early breast cancer ? - Antoinette R Tan; Seock-Ah Im; Andre Mattar; Ramon Colomer; Daniil Stroyakovskii; Zbigniew Nowecki; Michelino De Laurentiis; Jean-Yves Pierga; Kyung Hae Jung; Christian Schem; Sarah Heeson; Mahesh Shivhare; et al. (Cancer Research, 2020)